filmov
tv
MCAD Manifestations of GU and GI disease - Dr. Anne Maitland - 2022
Показать описание
This video is from our 2022 Global Learning Conference.
Dr. Anne Maitland covers pertinent points regarding the management of MCAD (Mast Cell Activation Disorders) and the GI/GU tracts in Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD).
Anne Maitland received a Bachelor of Science, in the biology, from Yale University and then earned her doctorates in Medicine and Philosophy from the University of Pennsylvania. Dr. Maitland completed an Internal Medicine residency at Brigham and Women's Hospital in Boston, and then Allergy & Clinical Immunology Fellowship training at Brigham and Women's Hospital and Icahn School of Medicine at Mt Sinai in New York. She is an Assistant Professor at Mt Sinai, in the Department of Medicine- Allergy/Immunology division, delivers in-office care, in Tarrytown, NY, as well as at the multi-discipline EDS center at Mt Sinai-South Nassau Community Hospital, and telehealth consultations, with Clinical Paradigms. Dr. Maitland is a member of Immunology faculty of the National Medical Association and serves as chair of the Mast Cell Disorders workgroups for American Academy of Allergy, Asthma and Immunology and the Ehlers-Danlos Syndromes International Consortium.
Dr. Anne Maitland covers pertinent points regarding the management of MCAD (Mast Cell Activation Disorders) and the GI/GU tracts in Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD).
Anne Maitland received a Bachelor of Science, in the biology, from Yale University and then earned her doctorates in Medicine and Philosophy from the University of Pennsylvania. Dr. Maitland completed an Internal Medicine residency at Brigham and Women's Hospital in Boston, and then Allergy & Clinical Immunology Fellowship training at Brigham and Women's Hospital and Icahn School of Medicine at Mt Sinai in New York. She is an Assistant Professor at Mt Sinai, in the Department of Medicine- Allergy/Immunology division, delivers in-office care, in Tarrytown, NY, as well as at the multi-discipline EDS center at Mt Sinai-South Nassau Community Hospital, and telehealth consultations, with Clinical Paradigms. Dr. Maitland is a member of Immunology faculty of the National Medical Association and serves as chair of the Mast Cell Disorders workgroups for American Academy of Allergy, Asthma and Immunology and the Ehlers-Danlos Syndromes International Consortium.
0:20:59
MCAD Manifestations of GU and GI disease - Dr. Anne Maitland - 2022
0:36:42
Neuropsychiatric Manifestations of Mast Cell Activation Disease (MCAS) - Dr. Anne Maitland - ASAP
0:50:27
Anaphylaxis, Mast Cell Activation Syndrome, or Something Else?
0:59:49
Mast Cell Activation Syndrome & Dysautonomia - Dr. Lawrence Afrin
0:19:58
Gastrointestinal Concerns in HSD and EDS - Dr. Laura Pace - 2022
1:14:41
Mast Cell Activation Disease Current Concepts
0:00:43
Rigid-Flex Board Planning Mode | Altium Designer 21 Sneak Peek
0:31:30
Understanding Mast Cell Activation in EDS & HDS - Dr. Anne Maitland | French (FR)
0:31:30
Understanding Mast Cell Activation in EDS & HDS - Dr. Anne Maitland | Italian (ITA)
0:06:30
YC5 - Mexican American Cultural Center Closer to Reality
0:05:56
SOLIDWORKS - Using Color in Sketches
0:51:27
mCAD Colby Teaches Standpipe Detail modeling with SketchUp in 3D
0:01:12
PCB Shapes
0:03:17
Component Placement in Rigid-flex Design PCB | ECAD and MCAD
0:03:15
Turmeric Maybe Just As Good As Omeprazole | Dr. Reena Mehta | Uptown Allergy & Asthma
0:36:11
Layer by layer LIVE - EagleCAD to Fusion 360
0:19:56
Stand Out in Your Medical School Interviews
2:01:21
Hi Risk/Recurrent/Advanced PCa Men & Caregivers Jan 15, 2018
0:01:31
Arati Artists Gallery 2020 April Artwalk
0:16:44
MKAD Farko by Custom Knife Factory-Unboxing and First Impressions!
1:30:15
Dr. Gisela Chelimsky presents “Hypermobile EDS and Gastrointestinal Issues”
0:31:46
1 1
0:53:59
Rural Health Matters RFD broadcast on September 25, 2023
0:58:58
Jill Brook Nutritionist Researcher talks about POTS Low Dose Naltrexone (LDN)
Комментарии